Materias dentro de su búsqueda.
Mostrando 21 - 40 Resultados de 102 Para Buscar 'Canadian Agency for Drugs and Technologies in Health', tiempo de consulta: 0.10s Limitar resultados
  1. 21
    Pharmacoeconomic review report : Mifepristone and misoprostol (Mifegymiso)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  2. 22
    Pharmacoeconomic review report : Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  3. 23
    Pharmacoeconomic review report : Ivabradine hydrochloride (Lancora)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  4. 24
    Pharmacoeconomic review report Emtricitabine/tenofovir alafenamide (Descovy)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  5. 25
    Pharmacoeconomic review report Empagliflozin and Metformin fixed-dose combination (Synjardy)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  6. 26
    Pharmacoeconomic review report Efinaconazole (Jublia) (Valeant Canada LP)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  7. 27
    Pharmacoeconomic review report Edoxaban (Lixiana)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  8. 28
    Pharmacoeconomic review report Dolutegravir (Tivicay)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  9. 29
    Pharmacoeconomic review report Dapagliflozin (Forxiga)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  10. 30
    Pharmacoeconomic review report Daclizumab (Zinbryta)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  11. 31
    Pharmacoeconomic review report Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  12. 32
    Pharmacoeconomic review report Apomorphine (Movapo) (Paladin Labs, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  13. 33
    Pharmacoeconomic review report Adalimumab (Humira)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  14. 34
    Pharmacoeconomic review report AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  15. 35
    Pharmacoeconomic report : indication : major depressive disorder in adults. Esketamine hydrochloride (Spravato) (Janssen inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  16. 36
    Patient group input submissions Selexipag (Uptravi) for pulmonary arterial hypertension (WHO class II and III)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  17. 37
    Patient group input submissions Sapropterin dihydrochloride (Kuvan) for phenylketonuria (PKU)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  18. 38
    Patient group input submissions Propiverine hydrochloride (Mictoryl) for overactive bladder
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  19. 39
    Patient group input submissions Omalizumab (Xolair) for asthma, severe persistent
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  20. 40
    Patient group input submissions Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico

Herramientas de búsqueda: